We are live on
!
Find out more
EC
EntryPoint Capital Portfolio holdings
AUM
$341M
1-Year Est. Return
20.57%
This Fund
S&P 500
This Quarter
Est. Return
-8.17%
1 Year Est. Return
+20.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$218M
AUM Growth
-$19.5M
(-8.2%)
Cap. Flow
+$3.51M
Cap. Flow
% of AUM
1.61%
Top 10 Holdings %
Top 10 Hldgs %
4.42%
Holding
1,001
New
307
Increased
177
Reduced
167
Closed
349
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AtriCure
ATRC
|
+$934K |
| 2 |
MASI
Masimo
MASI
|
+$931K |
| 3 |
Palladyne AI
PDYN
|
+$929K |
| 4 |
Equity Lifestyle Properties
ELS
|
+$926K |
| 5 |
BorgWarner
BWA
|
+$898K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Carlyle Group
CG
|
+$962K |
| 2 |
GeneDx Holdings
WGS
|
+$933K |
| 3 |
Viasat
VSAT
|
+$852K |
| 4 |
INFA
Informatica
INFA
|
+$807K |
| 5 |
Amgen
AMGN
|
+$804K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.61% |
| 2 | Technology | 17.16% |
| 3 | Industrials | 15.49% |
| 4 | Financials | 11.59% |
| 5 | Consumer Discretionary | 10.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XHR
551
Xenia Hotels & Resorts
XHR
$1.98B
| $188K | 0.09% |
+16,017
| New | +$223K |
|
|
SEMR
552
DELISTED
Semrush
SEMR
| $188K | 0.09% |
20,152
+781
| +4% | +$10.6K |
|
553
Relay Therapeutics
RLAY
$4.02B
| $187K | 0.09% |
71,486
+49,161
| +220% | +$193K |
|
554
EyePoint Inc
EYPT
$1.02B
| $186K | 0.09% |
+34,324
| New | +$240K |
|
555
Viridian Therapeutics
VRDN
$2.13B
| $185K | 0.08% |
+13,742
| New | +$234K |
|
556
Stagwell
STGW
$1.84B
| $184K | 0.08% |
+30,429
| New | +$191K |
|
557
Cullinan Oncology
CGEM
$1.05B
| $183K | 0.08% |
24,190
+9,533
| +65% | +$91.5K |
|
558
Avanos Medical
AVNS
$1.17B
| $181K | 0.08% |
+12,658
| New | +$198K |
|
559
Peabody Energy
BTU
$2.78B
| $181K | 0.08% |
+13,358
| New | +$215K |
|
|
PLGO
560
Pelagos Insurance Capital
PLGO
$2.19B
| $181K | 0.08% |
+11,155
| New | +$178K |
|
561
Coursera
COUR
$1.54B
| $180K | 0.08% |
+26,984
| New | +$214K |
|
562
Wipro
WIT
$18.5B
| $178K | 0.08% |
+58,143
| New | +$198K |
|
|
FPI
563
Farmland Partners
FPI
$419M
| $178K | 0.08% |
+15,950
| New | +$183K |
|
564
Tactile Systems Technology
TCMD
$620M
| $178K | 0.08% |
13,432
-6,053
| -31% | -$95.2K |
|
|
KE
565
Kimball Electronics
KE
$598M
| $177K | 0.08% |
+10,767
| New | +$190K |
|
|
OSG
566
Octave Specialty Group
OSG
$252M
| $177K | 0.08% |
+20,235
| New | +$213K |
|
567
Ecopetrol
EC
$32.9B
| $171K | 0.08% |
16,380
-595
| -4% | -$5.68K |
|
568
Corvus Pharmaceuticals
CRVS
$1.1B
| $171K | 0.08% |
53,745
-62,900
| -54% | -$296K |
|
569
Spok Holdings
SPOK
$221M
| $170K | 0.08% |
+10,322
| New | +$168K |
|
570
Organon & Co
OGN
$3.55B
| $170K | 0.08% |
11,392
-16,547
| -59% | -$254K |
|
|
WSR
571
DELISTED
Whitestone REIT
WSR
| $169K | 0.08% |
+11,570
| New | +$159K |
|
572
Cogent Biosciences
COGT
$6.79B
| $168K | 0.08% |
28,005
-24,341
| -47% | -$191K |
|
|
RC
573
Ready Capital
RC
$265M
| $167K | 0.08% |
+32,767
| New | +$202K |
|
|
OPRA
574
Opera Ltd
OPRA
$1.65B
| $166K | 0.08% |
10,438
-830
| -7% | -$15.4K |
|
575
MannKind Corp
MNKD
$1.28B
| $165K | 0.08% |
+32,781
| New | +$184K |
|
Similar funds
SFA
FCM
CPI
SW
MTIC
KFSC
YCM
SC
EntryPoint Capital's Q1 2025 Portfolio in Review
As of Q1 2025, EntryPoint Capital held 1,001 positions worth $218M, down 8.2% from $238M the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.
EntryPoint Capital's Q1 2025 filing shows 307 new, 177 increased, 167 reduced and 349 closed positions. Its largest new stake was AtriCure: 25,168 shares worth $812K. The largest sale was Carlyle Group, an estimated $962K.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.
- EntryPoint Capital's largest Q1 2025 buy was AtriCure: 25,168 shares worth $812K.
- EntryPoint Capital added most to Amphenol in Q1 2025, an estimated $815K increase.
- EntryPoint Capital's biggest Q1 2025 reduction was Harmony Biosciences, cutting an estimated $692K.
- EntryPoint Capital fully exited Carlyle Group in Q1 2025, selling an estimated $962K.
- EntryPoint Capital's ten largest holdings make up 4.4% of its $218M portfolio in Q1 2025.
- EntryPoint Capital opened 307 new positions and closed 349 in Q1 2025.
- EntryPoint Capital's portfolio value fell 8.2% quarter-over-quarter to $218M.
Based on EntryPoint Capital's 13F filing for Q1 2025, filed 14 May 2025.